Free account + included starter software — credential review typically takes 1–2 business days. See how it works
TRIAMCINOLONE ACETONIDE CREAM 0.001 30GM TUBE - 1 mg/g CREAM
Request Item

TRIAMCINOLONE ACETONIDE CREAM 0.001 30GM TUBE

Generic: TRIAMCINOLONE ACETONIDE

TRIAMCINOLONE ACETONIDE CREAM 0.001 30GM TUBE

NDC:67877-0251-30
Manufacturer:Ascend Laboratories, LLC
Strength:1 mg/g
Dosage Form:CREAM
Route:TOPICAL

Sign up to see pricing

Licensed pharmacies, clinics, doctor's offices, and veterinary practices get instant account approval

Sign Up — Instant Approval

Drug Information

Identification

Generic Name

TRIAMCINOLONE ACETONIDE

Brand Name

TRIAMCINOLONE ACETONIDE

Labeler / Distributor

Ascend Laboratories, LLC

Product Type

HUMAN PRESCRIPTION DRUG

Administration

Dosage Form

CREAM

Route of Administration

TOPICAL

FDA Application Number

ANDA088042

Active Ingredients

IngredientStrength
TRIAMCINOLONE ACETONIDE1 mg/g

Pharmacological Class

Corticosteroid Hormone Receptor Agonists [MoA]Corticosteroid

Data sourced from openFDA / DailyMed. For full prescribing information, consult the drug label.

Clinical Drug Information

Indications & Usage

INDICATIONS & USAGE Topical corticosteroids are indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses.

Dosage & Administration

DOSAGE & ADMINISTRATION Topical corticosteroids are generally applied to the affected area as a thin film two to four times daily for the 0.025% strength and two or three times daily for the 0.1% and 0.5% strength depending on the severity of the condition. Occlusive dressings may be used for the management of psoriasis or recalcitrant conditions. If an infection develops, the use of occlusive dressings should be discontinued and appropriate antimicrobial therapy instituted.

Adverse Reactions

ADVERSE REACTIONS The following local adverse reactions are reported infrequently with topical corticosteroids, but may occur more frequently with the use of occlusive dressings. These reactions are listed in an approximate decreasing order of occurrence: burning, itching, irritation, dryness, folliculitis, hypertrichosis, acneiform eruptions, hypopigmentation, perioral dermatitis, allergic contact dermatitis, maceration of the skin, secondary infection, skin atrophy, striae, and miliaria.

Information for Patients

INFORMATION FOR PATIENTS Patients using topical corticosteroids should receive the following information and instructions: 1. This medication is to be used as directed by the physician. It is for external use only. Avoid contact with the eyes. 2. Patients should be advised not to use this medication for any disorder other than for which it was prescribed. 3. The treated skin area should not be bandaged or otherwise covered or wrapped as to be occlusive unless directed by the physician 4. Patients should report any signs of local adverse reactions especially under occlusive dressing. 5. Parents of pediatric patients should be advised not to use tight-fitting diapers or plastic pants on a child being treated in the diaper area, as these garments may constitute occlusive dressings.

Clinical data sourced from openFDA drug labeling. For complete prescribing information, consult the full drug label.